FDA Grants AP Status for Ramelteon ANDA 215243 by Micro Labs
The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Ramelteon submitted by Micro Labs.
Asset / Drug
Drug and asset intelligence for Ramelteon with 5 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Melatonin Receptor Agonist
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.